Tata Memorial Centre Publishes First of its Kind Study on the Cost of Illness and Treatment of Oral Cancer In India. This is the first such study in India and among a handful globally.
About:
According to the World Health Organization (WHO), cancer is the second leading cause of death globally, with approximately 70% cancer cases occurring in low and middle-income countries.
India’s cancer scenario is burdened with oral cavity cancer being the most common among men. In fact, India accounted for almost a third of the global incidence in 2020.
As per the GLOBOCAN statistics, the rate of new cases being diagnosed has increased by a staggering 68% in the past two decades alone.
As per the GLOBOCAN statistics, the rate of new cases being diagnosed has increased by a staggering 68% in the past two decades alone
the unit cost of treating advanced stages (Rs. 2,02,892/- ) was found to be 42% greater than early stages (Rs. 1,17,135/-).
Medical equipment accounted for 97.8% of capital costs, with the highest contributor being the radiology services that included CT, MRI and PET scan.
India spent approximately Rs. 2,386 crores in 2020 on oral cancer treatment, paid for by insurance schemes, government and private sector spending, out of pocket payments and charitable donations or a combination of these.
Without any inflation in costs, this will result in an economic burden on the country of 23,724 crores over the next ten years.
Dear Student,
You have still not entered your mailing address. Please enter the address where all the study materials will be sent to you. (If applicable).
